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Introduction
In the second half of the last century, Pseudomonas aeruginosa has become an important hospital pathogen. 1 It needs minimal nutritional requirements for growth. It is a commensal of human microflora in healthy people. This rate of commensalism increases gradually with the increased duration of hospital stay. 2 This bacteria is frequently isolated as an opportunistic pathogen in recurrent infections of hospitalized patients and has been isolated from a number of sites in the hospital environment. 3, 4 P. aeruginosa is the most important, resistant and dangerous organism infecting the burn patients. 5 It is the fifth common pathogen among hospital microorganisms and causes 10% of all hospital-ciprofloxacin. All (100%) of the P. aeruginosa isolated from tracheal aspirates were resistant to ciprofloxacin, ceftazidime, ceftriaxone, cefixime and amikacin. The resistance pattern of cotrimoxazole varied from 33% to 94% in different clinical specimens. (Table III) About 95% of the total samples were wound swab, pus, urine, and aural swab. Nearly half (129, 44.0%) of the P. aeruginosa was isolated from wound swab only, among which 13% were from the casualty wards, 11% from surgical outdoor, 10% from burn unit and the rest from other locations. Majority of the samples included were wound swab (129, 43.88%), urine (86, 29.25%), pus (33, 11.23%) and aural swab (31, 10.54%). Almost all of the aural swabs (29, 93.55%) were collected from Out Patients Department. (Table II) The resistance rate (%R) of P. aeruginosa isolated from different specimens to different antimicrobials varied greatly. Organisms isolated from wound swab and pus samples were more resistant to azithromycin (100%), cefixime (93.3%), ceftazidime (86.8%), ceftriaxone (86.1%) and ciprofloxacin (75.5%). The only drug found least resistant (3.1%) was imipenem. Among the organisms isolated from aural swabs, the rate of resistance was 9.7% for amikacin and 13.3% for aspirate was very alarming, which ranged from 60-100%. It might be due to the fact that the patients were aged and were suffering from chronic illness. A high %R to antibiotics indicates the improper use of antibiotics in the hospital. 3 The result of this study indicates that commonly used drugs can no more be used as empirical therapy for suspected pseudomonad infections.
The number of patients admitted far exceeds the treatment facilities available in Dhaka Medical College Hospital. So, it can be concluded that every effort should be made for routine microbiological surveillance to reduce infections. It is also necessary to carry out a large-scale study with newer antimicrobials. This will hopefully reduce the resistance pattern and thus the treatment cost, and initiate quality patientcare.
Discussion
There is mounting evidence that proportion of resistance (%R) among P. aeruginosa isolates are increasing steadily. The rise in the rate of antimicrobial resistance to a specific antibiotic was greatest for ciprofloxacin, showing an absolute increase of 16%. 9 In addition to being intrinsically resistant, it can acquire resistance trait during therapy through an array of mechanisms.
In the present study, isolates of P. aeruginosa from wound swab and pus were found relatively more resistant than those from other specimens. The rate of resistance (%R) for azithromicin was 100%, cefixime 93.3%, cefrtiaxone and ceftazidime was 86%, ciprofloxacin 75.5% and amikacin 22.7%. Previous study in 2000-2001, in Bangladesh, showed that %R of P. aeruginosa to co-trimoxazole was 92%, ciprofloxacin 62.5%, cephalexin 100%, ceftriaxone 75% and ceftazidime 37%. 7 However, in another study, the resistance to amikacin was 2%, ceftriaxone 43%, ceftazidime 25% and ciprofloxacin 50%. 9 The number of multi-drug resistant strains has increased in recent years. An Iranian study in 2003 had their resistance pattern worse than this study, where the %R to gentamycin was 93.7%, ceftazidime 96%, amikacin 93% and ciprofloxacin 86%. 11 A five-year retrospective Indian study, from 1997-2002, found resistance pattern of P. aeruginosa as amikacin 52%, gentamycin 69%, ciprofloxacin 89%, and ceftazidime 62%, which shows that the trend of resistance was also increasing. Taneja in 2004 found the pattern of resistance about 90% each for ceftazidime and amikacin while 45 % for ciprifloxacin. 12 Regarding the urine samples, rate of resistance of the organism to azithromycin was 100%, nalidixic acid 82.6%, ciprofloxacin 72.2%, ceftazidime 71.2%, ceftriaxone 68.8% and gentamycin 63.5%. Another study in Bangladesh showed the %R to ciprofloxacin 29%, ceftazidime 12%, ceftriaxone 20% and gentamycin 37%. 9 The study of Shahnaz in 2002 found %R of P. aeruginosa isolated from urine as ceftazidime 94%, gentamycin and ciprofloxacin 90% and ceftriaxone 85%. 13 The increased %R to ciprofloxacin is frustrating. Some 11% specimens of the current study were aural swab, >90% of which was from the ENT OPD. The %R to cotrimoxazole was reported 85% in treating ear infection as found by Wadud et al. 9 The rate of resistance as observed in the present study to amikacin was 9.7%, to ceftriaxone and ciprofloxacin were 52% and 13%, respectively, which was 21% and 7% respectively in the previous study by Wadut et al. 9 The resistance pattern of P. aeruginosa found in tracheal
